NCT05354115View on ClinicalTrials.gov

Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.

NACompletedINTERVENTIONAL
Enrollment

676

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

August 22, 2022

Study Completion Date

August 22, 2022

Conditions
COVID-19Influenza AInfluenza Type B
Interventions
DIAGNOSTIC_TEST

Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel

Collection procedure will be a mid-turbinate nasal swab (deep nasal swab), by turning the swab five times in each nostril. After the nasal sampling, the operators will collect two nasopharyngeal swab one from each nostril of each subject.

Trial Locations (1)

29640

Urgent Care Clinical Trials Easley, Easley

All Listed Sponsors
lead

Abbott Rapid Dx

INDUSTRY